Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit cigarettes. The Food and Drug Administration OK'd 10 Zyn flavors,

The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious health conditions compared to cigarettes and smokeless tobacco products.

The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive scientific review" about their safety.